Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
FDA Approves Alembic’s Generic Acitretin Capsules for Psoriasis - The Dermatology Digest
Subscribe
Search

|

FDA Approves Alembic’s Generic Acitretin Capsules for Psoriasis

The U.S. Food Drug Administration (FDA) approved Alembic’s generic acitretin formulation for severe psoriasis.

Acitretin is an oral retinoid.

The company announced final approval from the FDA for its Abbreviated New Drug Application (ANDA) Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Soriatane Capsules, 10 mg, 17.5 mg, and 25 mg, of Stiefel Laboratories, Inc. (Stiefel).

Print Friendly, PDF & Email